According to Fate Therapeutics
's latest financial reports the company has $0.29 Billion USD in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.31 B | -27.75% |
2022-12-31 | $0.43 B | -29.17% |
2021-12-31 | $0.61 B | 27.54% |
2020-12-31 | $0.48 B | 118.09% |
2019-12-31 | $0.22 B | 10.16% |
2018-12-31 | $0.20 B | 99.12% |
2017-12-31 | $0.10 B | 9.59% |
2016-12-31 | $92.11 M | 42.13% |
2015-12-31 | $64.8 M | 31.99% |
2014-12-31 | $49.1 M | -9.13% |
2013-12-31 | $54.03 M | 494.65% |
2012-12-31 | $9.08 M | 42.27% |
2011-12-31 | $6.38 M |